References
- Koss L: The Papanicolaou staining test for cervical cancer detection-a triumph and a tragedy. JAMA 26:373–343, 1989
- Birdsong G: Automated rescreening of Papanicolaou smears. What are the implications? Diag Cytopath 13:283–286, 1995
- Grohs H, Husain NO: Automated Cervical Cancer Screening. Igacu-Shoin, New York, 1994
- Sherman M, Kelly D: High grade squamous intraepithelial lesions and invasive carcinoma followed report of three nega-tive Papanicolaou smears: screening failure or rapid progres-sion. Molec Path 5:1337–42, 1992
- Slater N, Milner PC, Radley H: Audit of deaths from cervical cancer: proposal for an essential component of the National Science Program. J Clin Path 47:27–8, 1994
- Mango L: Computer-assisted cervical cancer screening using neural network. Cancer Lett 77:155–62, 1994
- Boon M, Kok LP: Neural network processing can provide means to catch errors that slip through the screening of Pap smears. Diagn Cytopath 9:411–16, 1993
- Van Der Graaf Y, Vooijs GP, Gallard HJ et al: Screening errors in cervical cytology screening. Acta Cytol 31:434–438, 1987
- Baker A, Melcher DH: Rapid cervical cytology screening. Cytopathology 2:299–301, 1991
- Baker RW, Wadswort J, Brugal G et al: An evaluation of “rapid review” as a method of quality control of cervical smears using AxioHome microscope. Cytopathology 8:85–95, 1997
- Farrell DJ, Bilkhu S, Gibson L, Cummings L et al: Rapid screening of cervical smears as a method of internal quality control. Acta Cytol 41:251–60, 1997
- Dudding N: Rapid screening of cervical smears: An improved method of quality control. Cytopathology 6:95–99, 1995
- Markovic O, Markovic N: May acid phosphatase decrease Pap test false negative readings. J Nat Cancer Inst 89:1459, 1997
- Burstone MS: Enzyme Histochemistry and Its Application in the Study of Neoplasms. Academic Press, NY, 1962, pp 88–113
- Goldberg AF, Barka T: Acid phosphatase activity in human blood cells. Nature 189:297, 1962.
- Sigma Technical Bulletin No 387, 1993
- Markovic O, Markovic N, Rakic LJ: Quantitative Cytochem-istry of Enzymes. University in Belgrade, Academic Press, Belgrade, Yugoslavia, 1986
- Markovic O, Markovic N: Cytochemistry and immunocyto-chemistry in the classification of blood marrow and blood cells and in the diagnosis of hematologic disorders. In Electromnicroscopic Cytochemistry and hmnunocytochemistry in Biomedicine, Ogawa K, Barka T (eds). CRC Press, Boca Raton, 1993, pp 611–638
- Markovic N, Markovic O, Markovic S: Image processing as-sisted measurement of intracellular effects of enzyme targeted drugs. Cell Vis 2:71–78, 1995
- Papanicolaou GN, Traut HF: The diagnostic value of vaginal smears in carcinoma of the uterus. Am J Obstet Gynecol 42: 193–206, 1941
- Akimoto S, Mosai M, Akamura K: Tumor marker doubling time in patients with prostate cancer: determination of prostate specific antigen and prostatic acid phosphatase. Ettrop Urn! 27:207–12, 1995
- Yam LT, Li CL, Lam KW: Tartarate resistant isoenzyme in reticulum cells of leukemic reticuloendotheliosis. New Engl J Med 284:357–9, 1971
- Van Der Heuvel R, Mathieu E, Schoeters G et al: Stromal cells from murine developing hemopoietic organs: comparison of colony-forming unit of fibroblasts in long-term cultures. Intl J Dev Biol 35:33–41, 1991
- Sidqui M, Collins P. Vitte C et al: Osteoblast adherence and resorption activity of isolated osteoclasts on calcium sulphate heinihydrate. Biomaterials 16:1327–9, 1991
- Markovic O: Platelet acid phosphatase isoenzymes. II Con-gress of Yugoslavian Hematologists. Proceedings 1:801–5, 1974
- Markovic O: Cytochemistry of megakaryocytes. 2. Acid phos-phatase: separation of acid phosphatase isoenzymes. Mak Med Pregl 30:19–27, 1975
- Markovic O: Cytochemistry of megakaryocytes. 3. Acid phos-phatase. Method for cytochemical investigation. Zb Med Fak Skopie 22:99–117, 1976
- Markovic O, Shulman NR: Megakaryocyte maturation indi-cated by methanol inhibition of an acid phosphatase shared by megakaryocytes and platelets. In Megakaryocyte Biology and Cellular Properties, Ewatt B, Levin R (eds). Elsevier North Holland Inc, New York, 1981, pp 271–83
- Scambia G, Benedetti P, Ferradina G et al: Cathepsin D assay in ovarian cancer; correlation with pathologic features and receptors for estrogen, progesterone and epidermal growth factor. Br J Cancer 64:182–4, 1991
- Saeed S, Stock-Novak D, Pohlod R et al: Prognostic correla-tion of plasma cell acid phosphatase and beta-glucuronidase in multiple myeloma. Blood 78:3281–7, 1991
- Bunn P: Tumor markers. In Cecil Textbook of Medicine, Wingaarden J, Smith L, Bennett C (eds), WB Saunders Co, Philadelphia, 1992, pp 1034–1037
- Sloane B, Moin K, Sameni M: Membrane association of ca-thepsin B can be induced by transfection of human breast epithelial cells with .-cha-ras oncogene. J Cell Sci 107:373, 1994
- Garcia M, Derock D, Pujon P et al: Overexpression of trans-fected cathepsin D in transformed cells increases their malig-nant phenotype and metastatic potency. Oncogene 5:1809–1814, 1990
- Zbou R, Sanse WT, Hammond EH et al: Correlation of sur-vival with quantitative tissue staining of prostate specific acid phosphatase in patients with prostate cancer. Jut J Radiat Biol Phys 33:823–9, 1995
- Markovic O: Cervical acid phosphatase-Papanicolaou test. SBIR Project Proposal, NIH, Bethesda, MD, 1998 (unpub-lished data)